Serum exosomal and serum glypican-1 are associated with early recurrence of pancreatic ductal adenocarcinoma

BACKGROUND: The diagnostic performance and prognostic value of serum exosomal glypican 1 (GPC-1) in pancreatic ductal adenocarcinoma (PDAC) remain controversial. In this study, we detected serum exosomal GPC-1 using enzyme-linked immunosorbent assay (ELISA) and determined whether it serves as a pred...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Juan, Guo, Madi, Song, Yushuai, Liu, Shan, Liao, Ran, Zhang, Yu, Zhang, Yumin, Yang, Qi, Gu, Yuanlong, Huang, Xiaoyi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9614098/
https://www.ncbi.nlm.nih.gov/pubmed/36313694
http://dx.doi.org/10.3389/fonc.2022.992929

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9614098/
https://www.ncbi.nlm.nih.gov/pubmed/36313694
http://dx.doi.org/10.3389/fonc.2022.992929

Ejemplares similares